[1] Zhang S, Zhu J, Li H, et al.Associations of CYP2C19 and F2R genetic polymorphisms with platelet reactivity in Chinese ischemic stroke patients receiving clopidogrel therapy[J]. Pharmacogenet Genom, 2021, 32(4): 138-143.
[2] 钟诗龙,韩雅玲,陈纪言,等. 氯吡格雷抗血小板治疗个体化用药基因型检测指南解读[J]. 中国实用内科杂志,2015,35(1):38-41.
[3] Lee CR, Luzum JA, Sangkuhl K, et al.Clinical pharmacogenetics implementation consortium guideline for CYP2C19 genotype and clopidogrel therapy: 2022 Update[J]. Clin Pharmacol Ther, 2022, 112(5): 959-967.
[4] Stuckey TD, Kirtane AJ, Brodie BR, et al.Impact of aspirin and clopidogrel hyporesponsiveness in patients treated with drug-eluting stents: 2-year results of a prospective, multicenter registry study[J]. JACC-Cardiovasc Interv, 2017, 10(16): 1607-1617.
[5] Yi X, Zhou Q, Lin J, et al.Aspirin resistance in Chinese stroke patients increased the rate of recurrent stroke and other vascular events[J]. Int J Stroke, 2012, 8(7): 535-9.
[6] Krasopoulos G, Brister SJ, Beattie WS, et al.Aspirin "resistance " and risk of cardiovascular morbidity: Systematic review and meta-analysis[J]. Brit Med J, 2008, 336(7637): 195-198.
[7] Ansari N, Najafi S, Shahrabi S, et al.PEAR1 polymorphisms as a prognostic factor in hemostasis and cardiovascular diseases[J]. J Thromb Thrombolysis, 2021, 51(1): 89-95.
[8] Wigginton JE, Cutler DJ, Abecasis GR.A note on exact tests of Hardy-Weinberg equilibrium[J]. Am J Hum Genet, 2005, 76(5): 887-893.
[9] 马良鹏,梅明,刘剑敏,等. 武汉汉族人群阿司匹林抵抗易感基因血管内皮聚集受体-1 rs12041331位点多态性分析[J]. 中国临床药理学杂志,2020,36(8):947-949.
[10] 黄鹤归,董俊丽,林奕凯,等. 武汉汉族人群血小板内皮聚集受体1基因多态性所致阿司匹林抵抗的性别差异[J]. 中华老年心脑血管病杂志,2020,22(11):1182-1184.
[11] Estol CJ.Thrombolytic therapy of cerebrovascular disorders[J]. Rev Neurol, 1999, 29(12): 1301-1309.
[12] 陈淑华,岳蕴华,马艳婷,等. 阿司匹林代谢基因在心脑血管疾病治疗中的价值[J]. 临床检验杂志(电子版),2018,7(1):162-164.
[13] 杨秀峰,刘净,乔馨,等. 缺血性脑卒中患者抵抗阿司匹林干预与GP1BA基因多态性关系的探讨[J]. 中国实验诊学,2020,24(8):1251-1253.
[14] Simon T.Impact of genetic polymorphisms in the clinical response of oral inhibitors of the platelet P2Y12 adenosine diphosphate (ADP) receptor[J]. Ann Cardiol Angeiol, 2010, 59(Suppl 2): S42-S46.
[15] 齐超然. 阿司匹林抵抗患者股浅动脉支架植入术后替代治疗方案的有效性及安全性分析[D]. 郑州:郑州大学,2021.
[16] Aref HM, El-Khawas H, Elbassiouny A, et al.A randomized pilot study of the efficacy and safety of loading ticagrelor in acute ischemic stroke[J]. Neurol Sci, 2022, 44(2): 765-771. |
